Screener
Acadia Pharmaceuticals ACAD Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's asset turnover?
- Acadia Pharmaceuticals (ACAD) reported asset turnover of 0.8× in Q2 2026.
- How has Acadia Pharmaceuticals's asset turnover changed year-over-year?
- Acadia Pharmaceuticals's asset turnover decreased by 19.4% year-over-year, from 1× to 0.8×.
- What is the long-term trend for Acadia Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's asset turnover has grown at a 6.7% compound annual growth rate (CAGR), from 0.6× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Acadia Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude